醫揚

-0.20 (-0.22%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

90.3027成交張數19.21本益比2.27股價淨值比3.32%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	24	16	34.4%	1.61	39.70	12.1%	8.1%	-0.5	-0.5
2026Q1	23	16	29.7%	1.84	41.00	9.1%	6.6%	-0.8	-0.9
2025Q4	22	16	27.1%	2.17	40.19	7.2%	5.3%	0.3	0.3
2025Q3	21	15	28.3%	2.06	38.90	8.7%	6.2%	0.7	0.6
2025Q2	22	15	31.2%	1.86	38.13	8.4%	5.6%	0.2	0.2
2025Q1	21	16	23.7%	2.78	40.94	8.7%	6.4%	0.4	0.4
2024Q4	21	15	26.3%	2.43	39.99	11.8%	8.7%	0.6	0.6
2024Q3	21	15	29.1%	2.09	38.25	12.4%	8.6%	-0.1	-0.1
2024Q2	22	14	34.8%	1.77	43.18	15.7%	10.4%	-0.5	-0.6
2024Q1	22	16	28.5%	2.32	46.91	16.5%	11.8%	1.2	1.2
2023Q4	20	15	25.8%	2.85	45.10	17.6%	12.7%	0.5	0.5
2023Q3	21	15	31.4%	2.21	43.49	19.1%	13.0%	2.2	2.2
2023Q2	20	14	32.4%	2.21	40.86	19.4%	12.7%	0.2	-0.3
2023Q1	20	15	27.5%	3.05	43.65	15.7%	10.8%	0.6	0.4
2022Q4	20	14	28.8%	2.94	41.85	16.8%	11.1%	-0.2	-0.2
2022Q3	19	13	31.6%	2.62	39.44	17.8%	11.5%	0.7	0.7
2022Q2	20	12	35.9%	2.16	37.51	15.1%	9.2%	0.6	0.6
2022Q1	20	13	34.4%	2.31	43.60	12.8%	8.8%	0.4	0.4
2021Q4	17	10	39.2%	1.62	33.90	12.3%	8.2%	0.4	0.3
2021Q3	16	10	39.8%	1.54	31.41	12.7%	8.4%	0.1	0.1
2021Q2	16	9	42.6%	1.55	33.88	15.3%	9.4%	-0.7	-3.6
2021Q1	14	11	25.9%	2.55	38.63	17.5%	13.1%	0.4	0.3
2020Q4	14	10	24.4%	2.73	37.91	16.3%	12.0%	1.3	1.2
2020Q3	13	10	24.3%	2.71	35.41	15.3%	11.1%	1.2	1.2
2020Q2	14	9	33.4%	2.00	42.45	15.8%	10.3%	-0.1	-0.1
2020Q1	13	10	23.4%	2.95	45.85	19.1%	13.9%	-0.4	-0.5
2019Q4	14	10	26.0%	2.69	45.80	25.0%	18.5%	-0.1	-0.2
2019Q3	14	10	27.9%	2.53	43.65	22.1%	15.8%	1.9	1.9
2019Q2	14	9	34.7%	1.93	46.18	30.4%	19.8%	0.6	0.5
2019Q1	14	10	28.9%	3.68	47.97	26.3%	19.1%	1.4	1.4
2018Q4	12	9	23.3%	4.65	45.38	21.9%	16.7%	-0.6	-0.7
2018Q3	13	9	27.2%	3.84	45.38	24.2%	18.1%	0.9	0.8
2018Q2	12	8	32.8%	3.14	40.82	17.4%	11.7%	0.9	0.9
2018Q1	12	9	22.8%	4.79	43.69	12.0%	9.2%	0.5	0.5
2017Q4	11	9	22.8%	4.82	43.50	–	–	-0.0	-0.0
2017Q3	11	8	21.9%	5.29	41.89	–	–	0.4	0.4
2017Q2	12	8	30.9%	3.52	44.70	–	–	0.2	0.1
2017Q1	12	9	22.5%	5.03	49.50	–	–	0.6	0.6